CorMedix Advances on Preliminary Q4 Results, Business Updates (NASDAQ:CRMD)


Double exposure of abstract creative hologram of financial chart and world map on exterior background of modern business center, research and strategy concept

Igor Kutyaev/iStock via Getty Images

  • CorMedix (NASDAQ:CRMD) shares rose about 20% premarket after it reported its preliminary fourth-quarter results.
  • CorMedix reported preliminary net income of about $31 million for the fourth quarter of 2024 and about $43 million for fiscal 2024.
  • Adjusted EBITDA for Q4 2024 is expected to exceed $12 million.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *